The Valley Desk

NCT05712200 · Interventional trial

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Overall registry status Recruiting

Phase 3

Conditions Atrial Fibrillation (AF)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov